SHG · Healthcare

Cowealth Medical China Co.Ltd. (603122)

Diagnostics & Research

Cowealth Medical China Co.Ltd. (603122) is listed on SHG in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 603122

P/E ratio

18.00

Cowealth Medical China Co.Ltd. (603122) — FAQ

What is 603122's P/E ratio?

The price-to-earnings (P/E) ratio for Cowealth Medical China Co.Ltd. (603122) is 18.00 (data as of 2026-05-24).

Does Cowealth Medical China Co.Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for Cowealth Medical China Co.Ltd. (603122). Check the MyAverix Finance app for the latest dividend data.

What sector is Cowealth Medical China Co.Ltd. in?

Cowealth Medical China Co.Ltd. (603122) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is 603122 listed on?

603122 is listed on SHG.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)